LOGO
LOGO

Quick Facts

Hain Celestial Trims FY25 Organic Sales Growth Outlook; Q2 Results Miss Estimates

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

While reporting financial results for the second quarter on Tuesday, organic and natural products company Hain Celestial Group, Inc. (HAIN) trims its organic net sales growth guidance for the full year 2025.

For fiscal 2025, the company now projects organic net sales decline of 2 to 4 percent, compared to previous guidance for flat or better growth.

On average, 12 analysts polled expect the company to report a sales decline of 3.54 percent to $1.67 billion for the year.

For the second quarter, the company posted a net loss of $103.98 million or $1.15 per share, sharply wider than $13.54 million or $0.15 per share in the prior-year quarter. Excluding items, adjusted earnings for the quarter was $0.08 per share, compared to $0.12 per share in the year-ago quarter.

Net sales for the quarter declined 9.4 percent to $411.49 million from $454.10 million in the same quarter last year. Organic net sales were down 6.8 percent, when adjusted for foreign exchange, acquisitions, divestitures and discontinued brands.

The Street was looking for earnings of $0.12 per share on revenues of $431.01 million for the quarter.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

RELATED NEWS
Latest Updates on COVID-19